Axiom Worldwide


Integrity Life Sciences Announces Global Licensing Agreement for Axiom Worldwide INC’s Technology and Products

Tampa, FL, USA, JUNE 23rd, 2014: Integrity Life Sciences, LLC announced today, it has entered into an official global licensing agreement that grants Integrity the use of all of Axiom Worldwide INC‘s technology, products, US Patent and Trademark Offices assignments, logos and other forms of intellectual property. The previously arranged agreement specifically includes the flagship product DRX9000 True Spinal Decompression and its family of products, and all of its derivatives such as the DRX9000C. Integrity will soon release further information regarding its ongoing development and future plans for after-market service and support, to include: clinical research, marketing support, maintenance services, repairs, and capacity for manufacturing and sales.

Team Integrity is guided by the leadership of Mr. James Gibson and a staff of managers, engineers, technicians, quality and regulatory approval professionals with a cumulative 50 plus year track record in the health care industry, and demonstrated success in the Non-Surgical Spinal Decompression Industry.  Integrity Life Sciences manufactures its products with quality and safety standards as demonstrated by its FDA clearances together with compliance to global harmonized standards to include Mark CE and ISO 13485, allowing Integrity Life Sciences to distribute to countries all over the world. Integrity Life Sciences is committed to ongoing research and development in support of the worldwide healthcare community.

Prior to Integrity Life Sciences, Mr. Gibson founded Axiom Worldwide, Inc in 2001 and obtained multiple US FDA 510(k) clearances over the years. Axiom invented its flagship products, the DRX 9000 True Spinal Decompression System and the DRX9000C, for use in medical markets around the globe. These systems were created to provide relief of back and neck pain and symptoms associated with herniated discs, bulging or protruding intervertebral discs, degenerative disc disease, posterior facet syndrome, and sciatica.   The dedicated team at Integrity Life Sciences will continue to support Axiom Worldwide’s legacy devices while pursuing continued medical innovations throughout the world.

Integrity Life Sciences delivers a multitude of orthotic treatment options to address one of the most costly systemic ailments in the world, chronic low back and neck pain.  The advanced solution begins with the Integrity Spinal Care Systems, non-surgical spinal decompression therapy systems engineered to provide pain relief for compressive and degenerative conditions of the spine. Specifically, conditions that may be treated include: neck pain and back pain associated with herniated discs, protruding discs, degenerative disc disease, posterior facet syndrome, and sciatica. It achieves these effects through decompression of intervertebral discs, that is, unloading due to distraction and positioning. Additionally, Integrity offers the very effective Integrity Gel Support Brace. It is a lumbar support brace that is a fitting compliment to non-surgical spinal decompression therapy and was designed as an adjunct therapy for those suffering from back pain and with the back pain sufferer's needs in mind. The Integrity Gel Support Brace can be used with or without Integrity's non-surgical spinal decompression medical devices, and is an excellent treatment option for personal home use.

Legal Disclaimer: Integrity Life Sciences is a privately held internationally based company with partners located across the globe. The licensing agreement does not convey or transfer to Integrity any ownership or responsibility of any of Axiom Worldwide’s assets or liabilities and is strictly limited to a licensing arrangement with the current owners of Axiom Worldwide, INC’s intellectual property. Integrity achieves its mission of "Restoring Integrity to the Spine" through the exclusive use of many internationally patents, trademarks and other sources of unique and proprietary intellectual property.

For additional information please visit:

To schedule an interview please contact:  James Gibson, President & CEO

Telephone: 813-935-5500    Email: